A Study of Nivolumab in Combination with either Rucaparib, Docetaxel, or Enzalutamide in Men with Castration- Resistant Metastatic Prostate Cancer (17149)

A Study of Nivolumab in Combination with either Rucaparib, Docetaxel, or Enzalutamide in Men with Castration- Resistant Metastatic Prostate Cancer (17149)

Trial Category:
Genitourinary
Phase
II
Contact(s)
Mary Beth WIlwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Nebraska Cancer Specialists, Omaha, NE
 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members